Convalesce Inc
Regenerating neurons, restoring lives
United States · Founded 2018 · $250K raised
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- convalesce.co
- Total Funding
- $250K
- Last Round
- $250K SeedJul 2018
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.
About
Convalesce is developing a stem cell-based therapy for neurological conditions like Parkinson's disease. Their core innovation is AmGel, a brain-mimetic hydrogel matrix that improves stem cell survival by 300% post-transplantation and confines cells to the target area. The gel's nanoscale topography mimics the brain's extracellular matrix, guiding stem cell differentiation into target neuron types.
Summary
Convalesce Inc is a Biotech company based in United States, founded in 2018. It has raised $250K in total across 1 round, most recently a $250K Seed round in Jul 2018. Investors include SOSV and IndieBio.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jul 2018
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/convalesce-inc"><img src="https://indexed.vc/api/badge/company/convalesce-inc" alt="Convalesce Inc on Indexed.vc" width="260" height="76" /></a>